Amiodarone

Amiodarone

Form: Intravenous (IV) Injection

Strength: 150 mg/3 mL and 500 mg/10 mL

Reference Brands: Cordarone, Pacerone(US)

Category: Critical Care

Amiodarone is a broad-spectrum antiarrhythmic medication used for the treatment and prevention of life-threatening ventricular arrhythmias and atrial fibrillation. It is available in both oral (100 mg, 200 mg, 400 mg tablets) and IV (50 mg/mL) forms, typically supplied in 3 mL and 10 mL vials. Amiodarone works by prolonging the cardiac action potential and refractory period. Brands like Cordarone and Pacerone are widely used in the US, while the EU features Cordarone, Amiodarone Hameln, and Accord. Amiodarone is a high-priority cardiac care drug sourced through pharma B2B supply chains by hospitals, clinics, and institutional buyers.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.